Cargando…

Fractalkine (CX(3)CL1) enhances hippocampal N-methyl-d-aspartate receptor (NMDAR) function via d-serine and adenosine receptor type A2 (A(2A)R) activity

BACKGROUND: N-Methyl-d-aspartate receptors (NMDARs) play fundamental roles in basic brain functions such as excitatory neurotransmission and learning and memory processes. Their function is largely regulated by factors released by glial cells, including the coagonist d-serine. We investigated whethe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Scianni, Maria, Antonilli, Letizia, Chece, Giuseppina, Cristalli, Gloria, Di Castro, Maria Amalia, Limatola, Cristina, Maggi, Laura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765929/ https://www.ncbi.nlm.nih.gov/pubmed/23981568 http://dx.doi.org/10.1186/1742-2094-10-108

Ejemplares similares

Fractalkine/CX3CL1 engages different neuroprotective responses upon selective glutamate receptor overactivation
por: Lauro, Clotilde, et al.
Publicado: (2015)

Roles of N-Methyl-D-Aspartate Receptors (NMDARs) in Epilepsy
por: Chen, Shuang, et al.
Publicado: (2022)

Fractalkine Modulates Microglia Metabolism in Brain Ischemia
por: Lauro, Clotilde, et al.
Publicado: (2019)

EHMTI-0062. Expression of fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) in the trigeminal ganglia: implications for craniofacial nociception
por: Gazerani, P, et al.
Publicado: (2014)

Anti-n-Methyl-d-Aspartate-Receptor (NMDAR) Encephalitis in Association with Ovarian Teratoma
por: Ahmad, Javaad, et al.
Publicado: (2017)

CX(3)CR1 Deficiency Alters Hippocampal-Dependent Plasticity Phenomena Blunting the Effects of Enriched Environment
por: Maggi, Laura, et al.
Publicado: (2011)

Early expression of the fractalkine receptor CX3CR1 in pancreatic carcinogenesis
por: Celesti, G, et al.
Publicado: (2013)

Current Progress on Assessing the Prognosis for Anti-N-Methyl-D-Aspartate Receptor (NMDAR) Encephalitis
por: Wang, Hao, et al.
Publicado: (2020)

Association of CX3CR1 Gene Polymorphisms with Fractalkine, Fractalkine Receptor, and C-Reactive Protein Levels in Patients with Kidney Failure
por: Woźny, Łukasz, et al.
Publicado: (2021)

Polymorphism of the Fractalkine Receptor CX3CR1 and Systemic Sclerosis-associated Pulmonary Arterial Hypertension
por: Marasini, Bianca, et al.
Publicado: (2005)

38.3 ONGOING GERMINAL CENTRE REACTIONS CONTRIBUTE TO N-METHYL-D-ASPARTATE RECEPTOR (NMDAR) ANTIBODY PRODUCTION IN NMDAR-ANTIBODY ENCEPHALITIS
por: Makuch, Mateusz, et al.
Publicado: (2018)

Anti N-methyl-D-aspartate receptor (NMDAr) encephalitis during pregnancy: A case report
por: Dono, Fedele, et al.
Publicado: (2022)

Targeting Peripheral N-Methyl-D-Aspartate Receptor (NMDAR): A Novel Strategy for the Treatment of Migraine
por: Kalatharan, Veberka, et al.
Publicado: (2023)

The Chemokine CX3CL1 (Fractalkine) and its Receptor CX3CR1: Occurrence and Potential Role in Osteoarthritis
por: Wojdasiewicz, Piotr, et al.
Publicado: (2014)

Fractalkine receptor chemokine (CX3CR1) influences on cervical and lumbar disc herniation
por: Oh, In-Soo, et al.
Publicado: (2015)

Case Report: Cotard's Syndrome in Anti-N-methyl D-aspartate (NMDA) Receptor (Anti-NMDAR) Encephalitis
por: Taib, Nur Iwana Abdul, et al.
Publicado: (2022)

Fractalkine/CX3CL1 in Neoplastic Processes
por: Korbecki, Jan, et al.
Publicado: (2020)

Fractalkine (CX3CL1) and Its Receptor CX3CR1 May Contribute to Increased Angiogenesis in Diabetic Placenta
por: Szukiewicz, Dariusz, et al.
Publicado: (2013)

Fractalkine receptor (CX(3)CR1) deficiency sensitizes mice to the behavioral changes induced by lipopolysaccharide
por: Corona, Angela W, et al.
Publicado: (2010)

NYX‐2925 induces metabotropic N‐methyl‐d‐aspartate receptor (NMDAR) signaling that enhances synaptic NMDAR and α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionic acid receptor
por: Bowers, M. Scott, et al.
Publicado: (2019)

Clinical Features, Treatment, and Outcomes Among Chinese Children With Anti-methyl-D-aspartate Receptor (Anti-NMDAR) Encephalitis
por: Zhang, Min, et al.
Publicado: (2019)

Mechanosensitivity of N-methyl-D-aspartate receptors (NMDAR) is the key through which amyloid beta oligomers activate them
por: Fani, Giulia, et al.
Publicado: (2021)

Anti-N-Methyl-D-Aspartate Receptor (NMDAR) Encephalitis Associated With Mediastinal and Ovarian Teratomas: A Case Report
por: Lee, Sue Hyun, et al.
Publicado: (2023)

Comparative Analysis of the Occurrence and Role of CX3CL1 (Fractalkine) and Its Receptor CX3CR1 in Hemophilic Arthropathy and Osteoarthritis
por: Wojdasiewicz, Piotr, et al.
Publicado: (2020)

Fractalkine (CX3CL1) and Its Receptor CX3CR1: A Promising Therapeutic Target in Chronic Kidney Disease?
por: Cormican, Sarah, et al.
Publicado: (2021)

Elevated Expression of Fractalkine (CX3CL1) and Fractalkine Receptor (CX3CR1) in the Dorsal Root Ganglia and Spinal Cord in Experimental Autoimmune Encephalomyelitis: Implications in Multiple Sclerosis-Induced Neuropathic Pain
por: Zhu, Wenjun, et al.
Publicado: (2013)

Corrigendum to “Comparative Analysis of the Occurrence and Role of CX3CL1 (Fractalkine) and Its Receptor CX3CR1 in Hemophilic Arthropathy and Osteoarthritis”
por: Wojdasiewicz, Piotr, et al.
Publicado: (2020)

Prion Protein Is a Key Determinant of Alcohol Sensitivity through the Modulation of N-Methyl-D-Aspartate Receptor (NMDAR) Activity
por: Petit-Paitel, Agnès, et al.
Publicado: (2012)

An Ensemble Approach to Predict Schizophrenia Using Protein Data in the N-methyl-D-Aspartate Receptor (NMDAR) and Tryptophan Catabolic Pathways
por: Lin, Eugene, et al.
Publicado: (2020)

Overlapping anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis with neuromyelitis optica spectrum disorders: a case report
por: Pan, Jialin, et al.
Publicado: (2022)

Fractalkine/CX3CR1 signaling during neuropathic pain
por: Clark, Anna K., et al.
Publicado: (2014)

Fractalkine/CX(3)CR(1) Pathway in Neuropathic Pain: An Update
por: Silva, Rita, et al.
Publicado: (2021)

CX(3)CL1 (fractalkine) and its receptor CX(3)CR1 regulate atopic dermatitis by controlling effector T cell retention in inflamed skin
por: Staumont-Sallé, Delphine, et al.
Publicado: (2014)

Two Polymorphisms in the Fractalkine Receptor CX3CR1 Gene Influence the Development of Atherosclerosis: A Meta-Analysis
por: Wu, Jian, et al.
Publicado: (2014)

Translational neurophysiological biomarkers of N-methyl-d-aspartate receptor dysfunction in serine racemase knockout mice
por: Balla, Andrea, et al.
Publicado: (2020)

Aberrant methylation of N-methyl-D-aspartate receptor type 2B (NMDAR2B) in non-small cell carcinoma
por: Tamura, Hajime, et al.
Publicado: (2011)

14-3-3 proteins promote synaptic localization of N-methyl d-aspartate receptors (NMDARs) in mouse hippocampal and cortical neurons
por: Lee, Gloria S., et al.
Publicado: (2021)

Prebiotic feeding elevates central brain derived neurotrophic factor, N-methyl-d-aspartate receptor subunits and d-serine()
por: Savignac, Helene M., et al.
Publicado: (2013)

Examination of the Fractalkine and Fractalkine Receptor Expression in Fallopian Adenocarcinoma Reveals Differences When Compared to Ovarian Carcinoma
por: Gurler, Hilal, et al.
Publicado: (2015)

Role of Fractalkine/CX3CL1 and Its Receptor in the Pathogenesis of Inflammatory and Malignant Diseases with Emphasis on B Cell Malignancies
por: Ferretti, Elisa, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_a7mhb573dkiaierrnuq01rvi1q